PMS-Fluconazole 50 mg Tablets Recall Due to Incorrect Quantity
Areazine synthesizes this Health Canada recall directly from Health Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
Pharmascience Inc. is recalling one lot of PMS-Fluconazole 50 mg tablets because the affected batch may not contain the correct quantity of tablets.
What this Health Canada recall tells you, and what most readers miss
This notice was issued by Health Canada on June 23, 2026 and geographically references Canada. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Product & Food Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, health-canada, medication.
What Happened
The affected batch may not contain the correct quantity of tablets.
Which Products Are Affected
- Brand: Pharmascience Inc.
- Product Name: PMS-Fluconazole 50 mg tablets
- DIN: 02245643
- Dosage Form: Tablet
- Strength: Fluconazole 50 mg
- Lot Number: 662615
Depth of recall: Retailers.
What You Should Do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Why This Matters
Incorrect tablet quantity in this antifungal medication could result in improper dosing for patients.
Source
Original source: Health Canada Official Notice ↗
Related Product & Food Recalls
All Product & Food Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (979 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to June 23, 2026.
Frequently Asked Questions
Common questions about this Health Canada recall.